Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This annual PPI event brings together researchers and clinicians at the forefront of Parkinson’s research alongside patients and families.

Karolien Groenewald, Katarina Gunter and Michele Hu speaking at the OPDC Open Day in 2024
Karolien Groenewald, Katarina Gunter and Michele Hu speaking at the OPDC Open Day

The 7th OPDC Open Day was held in Oxford on Tuesday 10 September 2024 at the Leonardo Hotel, Oxford.  Of the 140 attendees, the majority were patients and families of the Oxford Discovery Cohort. Set up in 2010, this long-term observational study of Parkinson’s and prodromal Parkinson’s is a world-leading Parkinson’s biomarker cohort which has provided an excellent opportunity to understand more about how Parkinson's develops over time, and how Parkinson’s affects different people in different ways. 

The day was opened by Professor Michele Hu, welcoming all and giving an update on the latest PD trials, followed by a packed programme of speakers from OPDC, NDCN, OBRC and OUH including:  

  • Timothee Aubourg & Katarina Gunter on wearable tech and smartphone apps to track motor progression
  • Karolien Groenewald on RBD in prodromal PD and the upcoming clinical study
  • Sanjay Manohar & Tanja Zerenner on understanding cognitive problems in PD
  • Johannes Klein & Tamir Eisenstein on translational brain imaging
  • Jamil Razzaque (OUH) & Helen Knott (OUH) on the benefits of aerobic exercise and treadmill training
  • Annie Ziyi Zhao & Rory Smith (ICL) on brain donation
  • Kalina Naidoo on investigating fibroblasts from PD patients
  • Ludo Van Hillegondsberg on proteomics and ‘what we do with that armful of blood’

As well as talks, there were opportunities for Q&As with each speaker, plus plenty of refreshment breaks and lunch which gave attendees and clinicians the chance to speak to and learn from each other.   

Many of the audience were participants in trials and studies. For them the day offered insights into how research has progressed thanks to their contributions of time, data, skin samples, and in the words of the comedian Tony Hancock - which we enjoyed a clip of thanks to Ludo Van Hillegondsberg - ‘very nearly an armful’ of blood! 

This sentiment was reiterated by Kalina Naidoo in the closing slide of her talk as she said ‘Thank you… none of these experiments could be done without the help of patients’. 

All talks were recorded and will be available soon on the Oxford Parkinson's Disease Centre website. 

Similar stories

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Meeting the neuroscientists at Meeting Minds

Ben Seymour and Masud Husain joined the line up of speakers at this year's Meeting Minds event for Oxford alumni on 19 September

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

Celebrating NDCN at Thomas Willis Day 2026

Our annual event where we join together to celebrate our people and the work of our Department over the last year. Nearly 250 staff and students came together for this year's event on Tuesday 16 June at the Mathematical Institute.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship

Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.